Medicare Prescription Drug Price Negotiation Act of 2019
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2019-09-25 | Committee | Subcommittee Hearings Held. | House committee actions |
| 2019-01-25 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2019-01-08 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2019-01-08 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2019-01-08 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2019-01-08 | IntroReferral | Introduced in House | Library of Congress |